Olink

Olink®
Part of Thermo Fisher Scientific

Type 2 diabetes exacerbates changes in blood pressure-independent arterial stiffness: cross-sectional and longitudinal evidence from the SUMMIT study

Journal of Applied Physiology, 2023

Aizawa K., Gates P., Mawson D., Casanova F., Gooding K., Hope S., Goncalves I., Nilsson J., Khan F., Colhoun H., Natali A., Palombo C., Shore A.

Disease areaApplication areaSample typeProducts
Metabolic Diseases
CVD
Pathophysiology
Plasma
Olink Target 96

Olink Target 96

Abstract

We demonstrate in this study a greater BP-independent arterial stiffness β0 in people with type 2 diabetes (T2DM) compared to those without, and also a greater change in β0 over 3 yr in people with T2DM than those without. These findings suggest that the intrinsic properties of the arterial wall may change in a different and more detrimental way in people with T2DM and likely represents accumulation of cardiovascular risk.

Read publication ↗